We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
+6.58%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.55B
AUM Growth
+$102M
Cap. Flow
+$46.8M
Cap. Flow %
3.03%
Top 10 Hldgs %
47.84%
Holding
47
New
7
Increased
10
Reduced
12
Closed
9

Top Buys

Rank Stock Value
1
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$72.5M
2
BIIB icon
Biogen
BIIB
+$58.1M
3
HCA icon
HCA Healthcare
HCA
+$25.7M
4
CF icon
CF Industries
CF
+$16.6M
5
TGTX icon
TG Therapeutics
TGTX
+$15.1M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$50.3M
2
STJ
St Jude Medical
STJ
+$50.1M
3
MDCO
Medicines Co
MDCO
+$24.3M
4
KSU
Kansas City Southern
KSU
+$19.3M
5
TV icon
Televisa
TV
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 53.42%
2 Consumer Discretionary 8.4%
3 Communication Services 8.17%
4 Consumer Staples 5.94%
5 Industrials 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THC icon
26
Tenet Healthcare
THC
$20.4B
$25M 1.62%
905,691
+37,647
+4% +$1.11M
ATRA icon
27
Atara Biotherapeutics
ATRA
$76.9M
$22.9M 1.48%
40,639
+11,061
+37% +$5.31M
CMG icon
28
Chipotle Mexican Grill
CMG
$47.5B
$22.8M 1.47%
2,827,150
-554,100
-16% -$4.82M
PVG
29
DELISTED
PRETIUM RESOURCES INC.
PVG
$18.5M 1.19%
+1,651,328
New +$13.1M
MCRB icon
30
Seres Therapeutics
MCRB
$46.8M
$18.1M 1.17%
31,210
-4,351
-12% -$2.55M
BYD icon
31
Boyd Gaming
BYD
$6.35B
$17.6M 1.14%
958,111
– –
CRDF icon
32
Cardiff Oncology
CRDF
$66.7M
$14.9M 0.96%
45,703
– –
LXRX icon
33
Lexicon Pharmaceuticals
LXRX
$1.04B
$14.8M 0.95%
1,029,926
– –
CF icon
34
CF Industries
CF
$19.3B
$13.5M 0.87%
+559,781
New +$16.6M
MGP
35
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$13.3M 0.86%
+500,000
New +$11.9M
OPK icon
36
Opko Health
OPK
$1.01B
$10M 0.65%
1,072,733
-261,573
-20% -$2.66M
ADPT
37
DELISTED
Adeptus Health Inc
ADPT
$6.43M 0.42%
124,529
– –
SPNC
38
DELISTED
Spectranetics Corp
SPNC
$4.8M 0.31%
256,473
-492,169
-66% -$8.67M
CHRS icon
39
Coherus Oncology
CHRS
$219M
– –
-341,121
Closed -$7.24M
LNW
40
DELISTED
Light & Wonder
LNW
– –
-1,632,180
Closed -$15.4M
TV icon
41
Televisa
TV
$1.49B
– –
-648,825
Closed -$17.8M
UNH icon
42
UnitedHealth
UNH
$379B
– –
-390,016
Closed -$50.3M
WW
43
DELISTED
WW International
WW
– –
-123,831
Closed -$1.8M
WW
44
PUT
DELISTED
WW International
WW
– –
-300,000
Closed -$4.36M
VYNT
45
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
– –
-350
Closed -$149K
SPNE
46
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
– –
-618,684
Closed -$9.06M
STJ
47
DELISTED
St Jude Medical
STJ
– –
-911,008
Closed -$50.1M
1
2

Similar funds

SHFC
Safe Harbor Family Capital Chapel Hill, North Carolina $128M AUM
IUC
Ivory Union Consulting Road Town $128M AUM
PC
Pelham Capital London, United Kingdom $128M AUM 34.73% 1-Year Est. Return
SIM
Summitas Investment Management Mckinney, Texas $128M AUM
PIA
Prakash Investment Advisors Andover, Massachusetts $128M AUM 44.06% 1-Year Est. Return
S
Storgate Dallas, Texas $127M AUM
CF
Concorde Financial Dallas, Texas $127M AUM 24.97% 1-Year Est. Return
BC
Barnett & Company Chattanooga, Tennessee $129M AUM 14.9% 1-Year Est. Return

Bridger Management's Q2 2016 Portfolio in Review

As of Q2 2016, Bridger Management held 47 positions worth $1.55B, up 7% from $1.45B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Bridger Management deployed $46.8M of net new capital in Q2 2016, opening 7 new positions and adding to 10 existing holdings. Its largest new stake was MALLINCKRODT PUBLIC LIMITED COMPANY: 1,186,046 shares worth $72.1M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 51% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Medicines Co, an estimated $24.3M trimmed.

  • Bridger Management's largest Q2 2016 buy was MALLINCKRODT PUBLIC LIMITED COMPANY: 1,186,046 shares worth $72.1M.
  • Bridger Management added most to TG Therapeutics in Q2 2016, an estimated $15.1M increase.
  • Bridger Management's biggest Q2 2016 reduction was Medicines Co, cutting an estimated $24.3M.
  • Bridger Management fully exited UnitedHealth in Q2 2016, selling an estimated $50.3M.
  • Bridger Management's ten largest holdings make up 48% of its $1.55B portfolio in Q2 2016.
  • Bridger Management opened 7 new positions and closed 9 in Q2 2016.
  • Bridger Management's portfolio value rose 7% quarter-over-quarter to $1.55B.

Based on Bridger Management's 13F filing for Q2 2016, filed 15 Aug 2016.